388 results on '"NAPARSTEK E"'
Search Results
2. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study
3. Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma
4. Nonmyeloablative Allogeneic Stem Cell Transplantation: Towards Improving Efficacy of Immunotherapy Instead of Myeloablative Chemoradiotherapy
5. Donor Immunization Vaccination and Transfer of Donor Immunity to Bone Marrow Transplant Recipients in the Course of Allogeneic Cell Therapy for Prevention and Treatment of Relapse
6. Toward Improvement of Therapeutic Strategies in Leukemia by Amplification of the Immune Responses Against Leukemia
7. The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
8. Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma
9. Suicide after hematopoietic SCT: the story of AG
10. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen
11. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation
12. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
13. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
14. Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease
15. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases
16. Harvest of peripheral blood stem cell from patients with haematological malignancies is associated with a clinically significant reduction in platelets counts: P1101
17. Allo-PBSCT across ABO barriers: time to blood group conversion vis-à-vis molecular chimerism: P653
18. Fatal H1N1 influenza infection in an allo-SCT recipient
19. Gender discrimination in haematopoietic stem cell transplantation: is it real?: O423
20. T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression
21. Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation: Two case reports with successful response to plasmapheresis
22. Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP)
23. Use of Fiberoptic Bronchoscopy in Bone Marrow Transplant Recipients
24. Continuous Interleukin-2 Infusion Combined with Cyclophosphamide- Based Combination Chemotherapy in the Treatment of Hemato-Oncological Malignancies: Results of a Phase I–II Study
25. Toward Improvement of Therapeutic Strategies in Leukemia by Amplification of the Immune Responses Against Leukemia
26. Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerism
27. T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
28. The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers – two independent studies
29. P105 Decrease in intra- and extra-cellular free iron species and oxidative stress parameters and increase in serum and urinary hepcidin during treatment with deferasirox in iron-loaded patients with MDS
30. P099a The myelodysplastic syndromes (MDS): Is bone marrow examination always necessary?
31. Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma
32. ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
33. Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera
34. Preface
35. Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
36. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program
37. T-cell depleted bone marrow transplantation for plasma cell myeloma: Report of a case and review of the results of BMT for myeloma
38. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
39. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
40. Suicide after hematopoietic SCT: the story of AG
41. Rapid in vivo testing of drug response in multiple myeloma made possible by xenograft to turkey embryos
42. HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
43. P138 Myelodysplastic syndromes patients treated with recombinant erythropoietin show improved immunological functions
44. Immunologic approaches for breast cancer patients in the setting of stem cell transplantation
45. Immunotherapy of lymphoma by cytokines and allogeneic cell therapy
46. Immunotherapy With Recombinant Human Interleukin-2 and Recombinant Interferon-α in Lymphoma Patients Postautologous Marrow or Stem Cell Transplantation
47. Noncardiogenic Pulmonary Congestion following Bone Marrow Transplantation
48. Second transplantation using allogeneic peripheral blood stem cells in a β‐thalassaemia major patient featuring stable mixed chimaerism
49. Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT [letter; comment]
50. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.